Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Condition: Hypertensive Emergency-associated Hemolytic Uremic Syndrome Interventions: Drug: Soliris®; Drug: Renin angiotensin system blockers Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials